Global HIV Clinical Forum: Integrase Inhibitors, 16 July 2016, Durban

Global HIV Clinical Forum: Integrating Science and Clinical PracticeThis one-day workshop that focused on all things integrase was held just before the IAS 2016 conference in Durban.

The meeting has an excellent policy of putting slides for all oral presentations and webcasts of plenary talks as webcasts.

Highlights include a talk by Charles Boucher on the characteristics of integrase inhibitor drug resistance and cross resistance, including cases of late development of resistance to dolutegravir.

An additional report in this issue of HTB is:

• Raltegravir-based third-line ART in children and adolescents

Links to other websites are current at date of posting but not maintained.